论文部分内容阅读
目的探讨尼莫地平联合川芎嗪治疗慢性脑血管功能不全患者的临床效果。方法 46例慢性脑血管功能不全患者,使用随机数字表法分为观察组及对照组,各23例。对照组给予丹参川芎嗪单独注射治疗,观察组给予尼莫地平联合丹参川芎嗪治疗,观察两组患者的治疗效果以及不良反应发生率。结果观察组患者治疗总有效率为95.7%,高于对照组的82.6%,差异有统计学意义(P<0.05);观察组不良反应发生率为4.3%,低于对照组的21.7%,差异有统计学意义(P<0.05)。两组患者行肝肾功能以及血糖功能检查,结果均显示正常。结论尼莫地平联合川芎嗪治疗慢性脑血管功能不全有良好的临床效果,不良反应发生率低,值得临床推广。
Objective To investigate the clinical effect of nimodipine and ligustrazine in patients with chronic cerebrovascular insufficiency. Methods 46 patients with chronic cerebrovascular insufficiency were randomly divided into observation group and control group with 23 cases in each group. The control group was given Salviae miltiorrhizae ligustrazine injection alone. The observation group was treated with nimodipine and Salvia miltiorrhizae ligustrazine. The therapeutic effect and incidence of adverse reactions in the two groups were observed. Results The total effective rate of observation group was 95.7%, which was higher than that of control group (82.6%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in observation group was 4.3%, which was lower than that of control group (21.7% There was statistical significance (P <0.05). Two groups of patients with liver and kidney function and blood sugar function tests, the results showed normal. Conclusion Nimodipine combined with ligustrazine in the treatment of chronic cerebrovascular insufficiency has a good clinical effect, the incidence of adverse reactions is low, worthy of clinical promotion.